Ocugen, Inc. (NASDAQ:OCGN) has a beta value of 2.85 and has seen 71,870,104 shares traded in the recent trading session. The company, currently valued at $96.11 Million, closed the recent trade at $0.69 per share which meant it gained $0.14 on the day or 24.63% during that session. The OCGN stock price is -2421.74% off its 52-week high price of $17.4 and 75.36% above the 52-week low of $0.17. If we look at the company’s 10-day average daily trading volume, we find that it stood at 26.19 Million shares traded. The 3-month trading volume is 32.53 Million shares.

The consensus among analysts is that Ocugen, Inc. (OCGN) is an Overweight stock at the moment, with a recommendation rating of 2.5. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.03.

Ocugen, Inc. (NASDAQ:OCGN) trade information

Sporting 24.63% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Monday, Aug 10 when the OCGN stock price touched $0.802 or saw a rise of 16.93%. Year-to-date, Ocugen, Inc. shares have moved 28.12%, while the 5-day performance has seen it change 25.75%. Over the past 30 days, the shares of Ocugen, Inc. (NASDAQ:OCGN) have changed 207.86%. Short interest in the company has seen 107.83 Million shares shorted with days to cover at 3.31.

Wall Street analysts have a consensus price target for the stock at $0.98, which means that the shares’ value could jump 42.03% from current levels. The projected low price target is $0.7 while the price target rests at a high of $1.25. In that case, then, we find that the current price level is +81.16% off the targeted high while a plunge would see the stock lose 1.45% from current levels.

Ocugen, Inc. (OCGN) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +50.6% over the past 5 years. Earnings growth for 2020 is a modest +89.6%.

Ocugen, Inc. (NASDAQ:OCGN)’s Major holders

Insiders own 8.15% of the company shares, while shares held by institutions stand at 11.98% with a share float percentage of 13.04%. Investors are also buoyed by the number of investors in a company, with Ocugen, Inc. having a total of 17 institutions that hold shares in the company. The top two institutional holders are Renaissance Technologies, LLC with over 687.51 Thousand shares worth more than $193.26 Thousand. As of March 30, 2020, Renaissance Technologies, LLC held 0.92% of shares outstanding.

The other major institutional holder is Blackrock Inc., with the holding of over 645.99 Thousand shares as of March 30, 2020. The firm’s total holdings are worth over $181.59 Thousand and represent 0.87% of shares outstanding.

Also the top two Mutual Funds that are holding company’s shares are Vanguard Extended Market Index Fund and Fidelity Extended Market Index Fund. As of March 30, 2020, the former fund manager holds about 0.44% shares in the company for having 329385 shares of worth $92.59 Thousand while later fund manager owns 194.49 Thousand shares of worth $60.29 Thousand as of May 30, 2020, which makes it owner of about 0.26% of company’s outstanding stock.